Uncategorized

25

Mar

Chemence Receives EU MDR and MDSAP Certifications

Led by Vice President of Regulatory Affairs, Charnelle Thomas, Chemence Medical, Inc. has received CE Mark Certification for their sterile topical skin adhesives under the new Medical Device Regulations (MDR). The EU MDR is the set of regulations that governs the worldwide production and European distribution of medical devices. Compliance with this regulation is mandatory for Chemence Receives EU MDR and MDSAP Certifications

24

Oct

Meet us at MEDICA 2021

Meet Chemence team at Medica 2021 in Hall 16 / Booth J16 to learn about our Exofin®, DermaFlex®, Derma+Flex® QS™ High Viscosity Topical Skin Adhesives and Exofin Fusion® Wound Closure System with innovative self-adhering, curved mesh. Click here to review our showcased products and schedule appointment with Chemence | Hall 16 / J16 @ Medica Floor Meet us at MEDICA 2021

5

May

Chemence Opens New Research and Development Facility

Chemence Center of Excellence to focus on adhesive technology innovation Alpharetta, GA — Chemence, a global company with specialized expertise in the field of polymerizable technology, announced the opening of the Chemence Center of Excellence, a state-of-the-art research and development facility in Alpharetta, Georgia. The facility is home to a large team of Chemence’s scientists Chemence Opens New Research and Development Facility

9

Apr

Chemence Medical Receives FDA Approval for Exofin Fusion® Redesign

Medical technologies manufacturer improves patient care with enhanced skin closure system Alpharetta, GA — Chemence Medical, a world leader in medical cyanoacrylate devices and products, announced the U.S. Federal Drug Administration’s (FDA) 510(k) approval of the company’s redesigned exofin fusion® skin closure system. Exofin fusion combines a self-adhering flexible mesh strip and a fast-curing 2-octyl Chemence Medical Receives FDA Approval for Exofin Fusion® Redesign

25

Feb

Chemence Medical Receives FDA Clearance for Exofin® Tissue Adhesive

Alpharetta, Georgia – February 15, 2016 Chemence Medical, Inc., a manufacturer and distributor of adhesive-based medical devices, announced it received Food and Drug Administration clearance to market and sell Exofin®, a new topical skin adhesive for wound closure. Exofin enters the market as the fastest polymerizing 2-octyl cyanoacrylate topical adhesive available and as the highest Chemence Medical Receives FDA Clearance for Exofin® Tissue Adhesive